TransCode Therapeutics Inc. Gains 42.55%

Wed, Feb 15, 2023 at 07:13 PM
TransCode Therapeutics Inc. Gains 42.55%

TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.67, representing a gain of 42.6%. On Wed, Feb 15, 2023, RNAZ:NASDAQ touched a New 2-Week High of $0.67. The stock appeared on our News Catalysts scanner on Tue, Jan 31, 2023 at 05:34 PM in the 'BIOTECH' category. From Wed, Feb 01, 2023, the stock recorded 10.00% Up Days and 9.09% Green Days

The stock spiked on Wed, Feb 15, 2023 at $0.9 with a volume of 40M+.

About TransCode Therapeutics Inc. (RNAZ:NASDAQ)

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.